Patents Assigned to ARNATAR THERAPEUTICS, INC
  • Arnatar compounds and methods for enhanced cellular uptake
    Patent number: 12247047
    Abstract: This invention generally relates to the field of compounds and methods for enhanced cellular uptake. In particular, the invention relates to N-acetylgalactosamine compounds and their conjugates. Also provided are methods for the preparation of these molecules and possible uses thereof, in particular in medicine.
    Type: Grant
    Filed: August 1, 2024
    Date of Patent: March 11, 2025
    Assignee: ARNATAR THERAPEUTICS, INC
    Inventors: Derek Steiner, Xuehai Liang, Yangfeng Wang
  • Advanced RNA targeting (ARNATAR) for angiotensinogen
    Patent number: 12247204
    Abstract: Disclosed herein are Advanced RNA Targeting (ARNATAR) dsRNA compounds targeting angiotensinogen (AGT). Such compounds are useful in methods for reducing expression of AGT and for therapeutically treating RAAS associated diseases, disorders and/or conditions, or symptoms thereof in a subject.
    Type: Grant
    Filed: June 21, 2024
    Date of Patent: March 11, 2025
    Assignee: ARNATAR THERAPEUTICS, INC
    Inventors: Yen Lieu, Lingdi Zhang, Xuehai Liang, Yanfeng Wang